Olgu Sunumu
BibTex RIS Kaynak Göster

Vaxzevria COVID-19 aşısı sonrasında gelişen şiddetli büllöz pemfigoid

Yıl 2022, , 27 - 29, 31.05.2022
https://doi.org/10.33204/mucosa.993581

Öz

Pfizer ve Moderna COVID-19 aşılarına sekonder büllöz pemfigoid az sayıda olguda tanımlanmıştır. Bu,
Oxford-AstraZeneca Vaxzevria COVID-19 aşısı tarafından tetiklenen bildirilmiş ilk büllöz pemfigoid vakasıdır.
Olgunun ilk semptomları, aşının ilk dozundan dört hafta sonra ortaya çıkmış ve büllöz pemfigoid tanısı direkt
immünofloresan test ve BP180 antikor pozitifliği ile doğrulanmıştır.

Kaynakça

  • Wijayanti A, Zhao CY, Boettiger D, et al. The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for Bullous Pemphigoid: which one to use? Acta Derm Venereol 2017;97:24-31.
  • Tomayko MM, Damsky W, Fathy R, et al. Subepidermal blistering eruptions, including bullous pemphigoid, following Covid-19 vaccination. J Allergy Clin Immunol 2021;148:750-1.
  • Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol 2022;49:34-41.
  • Perez-Lopez I, Moyano-Bueno D, Ruis-Villaverde R. [Bullous pemphigoid and Covid-19 vaccine]. Med Clin (Barc) 2021;157:e333-e334.

Severe bullous pemphigoid after Vaxzevria COVID-19 vaccination

Yıl 2022, , 27 - 29, 31.05.2022
https://doi.org/10.33204/mucosa.993581

Öz

Bullous pemphigoid has been described in a small number of cases secondary to the Pfizer and Moderna COVID-19 vaccinations. This is the first reported case of bullous pemphigoid triggered by the Oxford-AstraZeneca Vaxzevria COVID-19 vaccination. His first symptoms occurred four weeks after his first dose, and were confirmed on direct immunofluorescence and with positive BP180 antibodies.

Kaynakça

  • Wijayanti A, Zhao CY, Boettiger D, et al. The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for Bullous Pemphigoid: which one to use? Acta Derm Venereol 2017;97:24-31.
  • Tomayko MM, Damsky W, Fathy R, et al. Subepidermal blistering eruptions, including bullous pemphigoid, following Covid-19 vaccination. J Allergy Clin Immunol 2021;148:750-1.
  • Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol 2022;49:34-41.
  • Perez-Lopez I, Moyano-Bueno D, Ruis-Villaverde R. [Bullous pemphigoid and Covid-19 vaccine]. Med Clin (Barc) 2021;157:e333-e334.
Toplam 4 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Klinik Tıp Bilimleri
Bölüm Case Reports
Yazarlar

Timothy Cowan 0000-0003-1212-269X

Lucinda Wallman Bu kişi benim 0000-0001-7080-9524

Dedee Murrell Bu kişi benim 0000-0003-2971-0199

Yayımlanma Tarihi 31 Mayıs 2022
Yayımlandığı Sayı Yıl 2022

Kaynak Göster

Vancouver Cowan T, Wallman L, Murrell D. Severe bullous pemphigoid after Vaxzevria COVID-19 vaccination. Mucosa. 2022;5(1):27-9.